Accreditation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: AMDA – The Society for Post-Acute and Long-Term Care Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ABPLM Designation Statement: This internet enduring material has been pre-approved by the American Board of Post-Acute and Long-Term Care Medicine (ABPLM) for a total of 1.5 management hours toward certification as a Certified Medical Director (CMD) in post-acute and long-term care medicine. The CMD program is administered by the ABPLM. Each physician should claim only those hours of credit actually spent on the activity.
Session Description: This session will review the positive outcomes of an effective advance care planning program across the long-term care continuum that leverages innovative and nationally recognized tools and resources. Participants will be able to employ new practical skills to improve their end-of-life discussions and documentation on Physician Orders for Life Sustaining Treatment (POLST) orders in the short-term, and apply the multidimensional approach needed to ensure effectiveness and sustainability of a POLST paradigm program in the PA/LTC setting.
Explain the IOM Report recommendations and apply pertinent policy and payment system actions with respect to advance care planning and the POLST Paradigm Program.
Demonstrate how eMOLST allows clinicians to follow a standard clinical process for the MOLST discussion, guides them through necessary documentation and ensures availability across care transitions.
Illustrate key functionality of the innovative eMOLST application and its current operation in NYS while reviewing customization options for use in any state's POLST/MOLST process.
Examine challenges, opportunities and lessons learned with end-of-life discussions, MOLST and eMOLST implementation.